All stock reports

ESAFSFB evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-07T14:00:58.920770+00:00

Metrics

latest_annual_period
2025-12-31
revenue
43482300000.0
net_income
-1664000000.0
operating_cash_flow
4920400000.0
free_cash_flow
2088600000.0
total_assets
308679800000.0
total_liabilities
290814500000.0
total_equity
17865300000.0
cash
11745300000.0
total_debt
27527400000.0
revenue_growth
0.004392460054123859
earnings_growth
-0.6808527981480257
net_margin
-0.03826844486147237
roe
-0.09314145298427678
debt_to_equity
1.540830548605397
cash_conversion
-2.956971153846154
free_cash_flow_margin
0.0480333377029274
trailing_pe
Not supplied
forward_pe
0.0
peg_ratio
Not supplied
price_to_book
1.1631
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-1bf576f934dd5f44722f6d2990e451c999d45795fb3fd69ad43525ac07c05438
Policy
stock-decisions-v1
Evidence bundle hash
4ab09c0dbc4cd0b65f2e439eeb5baa3ff21901d3be4cae24f997cc66ea2bf4ac
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 4d2127d557b75214c16333262867684c4609b5d2d685688fa262612057d3a156
  • daily-price: 4a6b3b4dc37217e90161ae9242e9b5b93f0609287008afb8af29ee12cd63a90e
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

The cached financial metric revenue growth is 0.004392460054123859. The cached financial metric free cash flow margin is 0.0480333377029274. The trailing 60-session price return was 32.40%. The trailing 250-session price return was 51.85%.

Risks

Financial data check: weak_cash_conversion: operating cash flow/net income below 0.5. The cached financial metric net margin is -0.03826844486147237. The cached financial metric roe is -0.09314145298427678. The closing price was -2.93% below its highest close in the available trailing year. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

Price source verification: REPAIRED. Fundamental coverage is FULL_STATEMENTS; retrieved 2026-09-07T14:00:58.920770+00:00 from EODHD. The cached financial metric latest annual period is 2025-12-31.

Cached observations and evidence limits